{"id":2147,"date":"2021-03-10T13:39:12","date_gmt":"2021-03-10T12:39:12","guid":{"rendered":"http:\/\/wtspatent.pl\/?page_id=2147"},"modified":"2021-07-21T12:04:32","modified_gmt":"2021-07-21T10:04:32","slug":"artykuly","status":"publish","type":"page","link":"https:\/\/wtspatent.pl\/en\/publikacje\/artykuly\/","title":{"rendered":"Articles"},"content":{"rendered":"<p><\/p>\n<ol>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/VIP-komentarz-AGR-na-strone-ENG.pdf\">&#8220;Visegrad Patent Institute (VPI) &#8211; easier way to international patent protection&#8221;<\/a>\u00a0(PDF)<\/li>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/The-Bolar-exemption-the-need-for-agreement.pdf\">&#8220;The Bolar exemption: the need for agreement&#8221;<\/a>\u00a0(PDF)<\/li>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/en6.pdf\">\u201cThe European Take on the Bolar Provision \u2013 the conclusion from Astellas vs. Polpharma\u201d<\/a>\u00a0(PDF)<\/li>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/en1.pdf\">&#8220;Patentability of the biotechnological inventions in Poland&#8221;<\/a>\u00a0\u0003(PDF)<\/li>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/en2.pdf\">&#8220;Special Provisions Governing Biotechnological Inventions in Poland&#8221;<\/a>\u00a0(PDF)<\/li>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/en3.pdf\">&#8220;Supplementary Protection Certificate (SPC) in Poland &#8211; basic regulations&#8221;<\/a>\u00a0(PDF)<\/li>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/en4.pdf\">&#8220;Ethics and Patentability in Biotechnology&#8221;<\/a>\u00a0(PDF)<\/li>\n<li><a href=\"http:\/\/wtspatent.pl\/wp-content\/uploads\/2014\/05\/en5.pdf\">&#8220;The First Year of SPC in Poland: A Tentative Summary&#8221;<\/a>\u00a0(PDF)<\/li>\n<\/ol>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>&#8220;Visegrad Patent Institute (VPI) &#8211; easier way to international patent protection&#8221;\u00a0(PDF) &#8220;The Bolar exemption: the need for agreement&#8221;\u00a0(PDF) \u201cThe European Take on the Bolar Provision \u2013 the conclusion from Astellas vs. Polpharma\u201d\u00a0(PDF) &#8220;Patentability of the biotechnological inventions in Poland&#8221;\u00a0\u0003(PDF) &#8220;Special Provisions Governing Biotechnological Inventions in Poland&#8221;\u00a0(PDF) &#8220;Supplementary Protection Certificate (SPC) in Poland &#8211; basic regulations&#8221;\u00a0(PDF) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2104,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"protect_children":false,"footnotes":""},"_links":{"self":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/2147"}],"collection":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/comments?post=2147"}],"version-history":[{"count":2,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/2147\/revisions"}],"predecessor-version":[{"id":2280,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/2147\/revisions\/2280"}],"up":[{"embeddable":true,"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/pages\/2104"}],"wp:attachment":[{"href":"https:\/\/wtspatent.pl\/en\/wp-json\/wp\/v2\/media?parent=2147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}